AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lieber, C. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lieber, C. S
Agricola
Right arrow Articles by Lieber, C. S
American Journal of Clinical Nutrition, Vol. 76, No. 5, 1183S-1187S, November 2002
© 2002 American Society for Clinical Nutrition


Supplements

S-Adenosyl-L-methionine: its role in the treatment of liver disorders1,2,3,4

Charles S Lieber

1 From the Mount Sinai School of Medicine and Alcohol Research Center, Section of Liver Disease and Nutrition, Bronx Veterans Affairs Medical Center, Bronx, NY.

S-Adenosyl-L-methionine (SAMe) exerts many key functions in the liver, including serving as a precursor for cysteine, 1 of 3 amino acids of glutathione—the major physiologic defense mechanism against oxidative stress. SAMe is particularly important in opposing the toxicity of free oxygen radicals generated by various pathogens, including alcohol, which cause oxidative stress largely by the induction of cytochrome P4502E1 (CYP2E1) and by its metabolite acetaldehyde. SAMe also acts as the main methylating agent in the liver. The precursor of SAMe is methionine, one of the essential amino acids, which is activated by SAMe-synthetase (EC 2.5.1.6). Unfortunately, the activity of this enzyme is significantly decreased as a consequence of liver disease. Because of decreased utilization, methionine accumulates and, simultaneously, there is a decrease in SAMe that acquires the status of an essential nutrient and therefore must be provided exogenously as a supernutrient to compensate for its deficiency. Administration of this innocuous supernutrient results in many beneficial effects in various tissues, mainly in the liver, and especially in the mitochondria. This was shown in alcohol-fed baboons and in other experimental models of liver injury and in clinical trials, some of which are reviewed in other articles in this issue.

Key Words: S-Adenosyl-l-methionine • SAMe • alcoholic liver injury • baboons • cholestasis • fibrosis • mitochondria • oxidative stress • liver disorders




This article has been cited by other articles:


Home page
J. Nutr.Home page
K. K. Kharbanda, D. D. Rogers II, M. E. Mailliard, G. L. Siford, A. J. Barak, H. C. Beckenhauer, M. F. Sorrell, and D. J. Tuma
A Comparison of the Effects of Betaine and S-Adenosylmethionine on Ethanol-Induced Changes in Methionine Metabolism and Steatosis in Rat Hepatocytes
J. Nutr., March 1, 2005; 135(3): 519 - 524.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. S Lieber and L. Packer
S-Adenosylmethionine: molecular, biological, and clinical aspects--an introduction
Am. J. Clinical Nutrition, November 1, 2002; 76 (5): 1148S - 1150S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The American Society for Nutrition